Egawa Takeshi, Taniuchi Ichiro
Kimmel Center for Biology and Medicine, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York 10016, USA.
Blood Cells Mol Dis. 2009 Jul-Aug;43(1):27-9. doi: 10.1016/j.bcmd.2009.03.004. Epub 2009 Apr 16.
Differentiation of CD4(+)CD8(+) double-positive (DP) thymocytes into either CD4(+)-helper or CD8(+)-cytotoxic lineages involves several phases. It has been suggested that, following initial specification to one of the lineages by a set of lineage-specific genes during positive selection, stable cell identity is established during the commitment process by eliminating differentiation potential toward the other lineage. While the Runx3 transcription factor fixes the Cd4 gene into a silenced state during cytotoxic-lineage cell differentiation, the ThPOK transcription factor is both necessary and sufficient to generate a CD4(+)CD8(-) phenotype in post-selection thymocytes, regardless of the MHC specificity of the TCRs. Recent studies have revealed that a reciprocal antagonistic interplay between Runx3 and ThPOK is a central component in the transcription factor network governing the helper versus cytotoxic-lineage decision.
CD4(+)CD8(+)双阳性(DP)胸腺细胞分化为CD4(+)辅助性或CD8(+)细胞毒性谱系涉及几个阶段。有人提出,在阳性选择过程中通过一组谱系特异性基因初步确定为其中一个谱系后,在定向过程中通过消除向另一个谱系的分化潜能来建立稳定的细胞身份。虽然Runx3转录因子在细胞毒性谱系细胞分化过程中将Cd4基因固定为沉默状态,但ThPOK转录因子对于在选择后的胸腺细胞中产生CD4(+)CD8(-)表型既必要又充分,而与TCR的MHC特异性无关。最近的研究表明,Runx3和ThPOK之间的相互拮抗作用是控制辅助性与细胞毒性谱系决定的转录因子网络的核心组成部分。